News for Trinity Biotech plc (TRIB)

Trinity Biotech (TRIB) introduces CGM+, an AI-native wearable targeting the $260 billion AI wearable market. CGM+ combines glucose monitoring with heart

Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Out...

DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc ( TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes man

**media[566986]**

DUBLIN and PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc ( TRIB), a commercial-stage biotechnology company focused on human diagnosti

Overview of the Recent Transaction On December 31, 2024, PERCEPTIVE ADVISORS LLC (Trades, Portfolio) made a significant move by acquiring 84,000,000 shares of T

**media[534015]**

Trinity Biotech (TRIB) stock gains on encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose monitoring ((CGM)) system. Read more here.

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

**media[495928]**

Trinity Biotech advances HIV test manufacturing to offshore site

Revenue: $15.2 million for Q3 2024, a 3% increase from Q3 2023.Point of Care Revenue: Increased by $2.7 million to $4.3 million, a 60% increase compared to Q3

Nov 15, 2024 / 03:00PM GMTOperator Greetings. Welcome to Trinity Biotech's third-quarter 2024 earnings conference call. (Operator instructions) As a reminder, t

Trinity Biotech Plc (NASDAQ:TRIB) Q3 2024 Earnings Conference Call November 15, 2024 10:00 AM ETCompany ParticipantsEric Ribner - Investor RelationsJohn...

**media[447009]**

**media[447007]**

Revenue: $15.8 million, a 14% increase compared to Q2 2023.Point-of-Care Revenue: $4.6 million, a 119% increase year-over-year.Clinical Laboratory Revenue: $11

Aug 14, 2024 / 12:30PM GMTOperator Welcome to the Trinity Biotech second-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conf

Edwards Lifesciences (EW) saw its stock surge by 5%, trading at $67.77 per share with a volume of 2.42 million shares. The stock witnessed a turnover rate of 0.